Literature DB >> 2225562

Acute deterioration of renal function associated with enteric hyperoxaluria.

R Wharton1, V D'Agati, A M Magun, R Whitlock, C L Kunis, G B Appel.   

Abstract

Enteric hyperoxaluria due to malabsorption syndromes has been well documented to cause renal calculi and chronic tubulointerstitial renal damage. Rarely, in the setting of intestinal bypass operations for morbid obesity, enteric hyperoxaluria has produced acute renal failure. We report two patients who suffered acute deterioration of renal function associated with increased intestinal absorption and renal excretion of oxalate associated with steatorrhea. One patient had a large portion of his small bowel resected many years prior to the onset of the renal failure and the second patient had chronic pancreatitis causing steatorrhea. Both patients had renal biopsy documentation of the acute nature of the tubular damage produced by oxalate deposition. The mechanisms of their deterioration of renal function may relate to sudden increases in steatorrhea in association with episodes of volume depletion. Enteric hyperoxaluria may be an easily overlooked and potentially preventable etiology of acute renal dysfunction.

Entities:  

Mesh:

Year:  1990        PMID: 2225562

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  18 in total

1.  Nephrolithiasis and nephrocalcinosis in rats with small bowel resection.

Authors:  R Corey O'Connor; Elaine M Worcester; Andrew P Evan; Shane Meehan; Dimitri Kuznetsov; Brett Laven; Andre' J Sommer; Sharon B Bledsoe; Joan H Parks; Fredric L Coe; Marc Grynpas; Glenn S Gerber
Journal:  Urol Res       Date:  2005-05

2.  Jejuno-ileal bypass, enteric hyperoxaluria, and oxalate nephrosis: a role for polarised light in the renal biopsy.

Authors:  K Hicks; G B Evans; M E Rogerson; P Bass
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

3.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

4.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

Review 5.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

6.  Genome wide analysis of differentially expressed genes in HK-2 cells, a line of human kidney epithelial cells in response to oxalate.

Authors:  Sweaty Koul; Lakshmipathi Khandrika; Randall B Meacham; Hari K Koul
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 7.  Management of primary hyperoxaluria: efficacy of oral citrate administration.

Authors:  E Leumann; B Hoppe; T Neuhaus
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 8.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 9.  Cell cultures and nephrolithiasis.

Authors:  C F Verkoelen; B G van der Boom; F H Schröder; J C Romijn
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

10.  Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.

Authors:  Przemysław Sikora; Bodo Beck; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Urol Res       Date:  2009-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.